Search Results 701-710 of 4439 for 留痕官网咨询邮箱：lgooxc@hotmail.com
This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Contact the Clinical Immunology and Immunotherapeutics Program at Mayo Clinic with inquiries about research, collaborations or junior faculty support.
... . IMG-20094062. Home; ddp-corp-and-foundation-giving-6col. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine ...
The purpose of this study is to execute a long-term retrospective observational cohort study of women who underwent screening mammography (defined as digital ...
Dr. Cerhan's team in the Lymphoma Epidemiology Lab at Mayo Clinic has expertise in cancer epidemiology, hematology, immunology, laboratory medicine and ...
Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...
A digital storytelling intervention will be developed to improve breast, cervical, and colorectal cancer screening rates among Hispanic, Spanish speaking ...
The purpose of this study is to analyze patient outcomes after ileal pouch anal anastomosis. Participation eligibility. Participant eligibility includes age, ...
... . IMG-20076720. Home; SM00055Deepwaterwalkingwithhandwebs. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.